| Product Code: ETC9397009 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Apixaban Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Apixaban Market - Industry Life Cycle |
3.4 South Korea Apixaban Market - Porter's Five Forces |
3.5 South Korea Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 South Korea Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 South Korea Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in South Korea |
4.2.2 Growing awareness about the benefits of using apixaban over traditional anticoagulants |
4.2.3 Rising geriatric population leading to higher demand for anticoagulant medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of apixaban in South Korea |
4.3.2 Competition from other anticoagulant drugs in the market |
4.3.3 Potential side effects associated with apixaban leading to concerns among healthcare professionals and patients |
5 South Korea Apixaban Market Trends |
6 South Korea Apixaban Market, By Types |
6.1 South Korea Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 South Korea Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 South Korea Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 South Korea Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 South Korea Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 South Korea Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 South Korea Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 South Korea Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 South Korea Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 South Korea Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 South Korea Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 South Korea Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 South Korea Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Apixaban Market Import-Export Trade Statistics |
7.1 South Korea Apixaban Market Export to Major Countries |
7.2 South Korea Apixaban Market Imports from Major Countries |
8 South Korea Apixaban Market Key Performance Indicators |
8.1 Number of prescriptions for apixaban in South Korea |
8.2 Percentage of patients switching to apixaban from traditional anticoagulants |
8.3 Patient adherence rate to apixaban treatment plan |
8.4 Number of clinical trials and studies conducted on apixaban in South Korea |
8.5 Rate of adverse events reported for apixaban in South Korea |
9 South Korea Apixaban Market - Opportunity Assessment |
9.1 South Korea Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 South Korea Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 South Korea Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Apixaban Market - Competitive Landscape |
10.1 South Korea Apixaban Market Revenue Share, By Companies, 2024 |
10.2 South Korea Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here